What is the appropriate dosing and administration of nystatin for oral thrush in a 15‑month‑old child?

Nystatin for Oral Thrush in a 15-Month-Old

For a 15-month-old child with oral thrush, administer nystatin oral suspension 100,000 IU (1 mL) four times daily for 7–14 days, applied directly to the affected oral mucosa after feeding. 1

Dosing and Administration

• Standard dose: Nystatin oral suspension 100,000 IU (1 mL) administered four times daily (every 6–8 hours) 1
• Duration: Continue treatment for 7–14 days, even if symptoms resolve earlier to prevent relapse 2
• Application technique: Apply the suspension directly to the affected areas of the oral cavity using the dropper; have the child retain it in the mouth as long as possible before swallowing 1
• Timing: Administer after feedings to maximize contact time with the oral mucosa 1

Important Clinical Considerations

Efficacy Limitations

• Nystatin has significantly lower cure rates compared to alternatives in multiple pediatric studies 3, 4, 5
• Clinical cure rates with nystatin suspension range from only 21–54% by day 8–12 of treatment, compared to 85–100% with fluconazole or miconazole 3, 4, 5
• In one randomized trial of infants, nystatin achieved only 32% clinical cure versus 100% with fluconazole 3
• A 2023 study found nystatin ineffective in reducing oral Candida carriage in children, with some isolates showing resistance mutations in the CDR2 gene 6

When to Consider Alternative Therapy

• If no clinical improvement occurs within 5–7 days, consider switching to fluconazole 3 mg/kg once daily for 7 days, which demonstrates superior efficacy 3, 5
• Miconazole oral gel (25 mg four times daily) is another alternative with 85–97% cure rates by day 5–8, significantly outperforming nystatin 4, 7
• However, the 2012 ESCMID guideline expresses concerns about miconazole generating triazole resistance 1

Safety Profile

• Nystatin is extremely safe with negligible systemic absorption and no known drug interactions 2, 8
• The most common adverse effects are poor taste and mild gastrointestinal symptoms 9
• Safety and effectiveness are established in the pediatric population from birth to 16 years 8
• No concerns exist for use in otherwise healthy infants and toddlers 8

Common Pitfalls to Avoid

• Inadequate contact time: Ensure the suspension coats the oral mucosa; administering immediately before feeding reduces efficacy 1
• Premature discontinuation: Parents may stop treatment when symptoms improve at 3–5 days, leading to relapse rates of 18–28% 5, 9
• Failure to recognize treatment failure: If thrush persists beyond 7 days of appropriate nystatin therapy, do not continue indefinitely—switch to a more effective agent 3, 4
• Not treating concurrent diaper candidiasis: If present, treat simultaneously to prevent reinfection 1

Monitoring and Follow-Up

• Reassess at 5–7 days: Clinical improvement should be evident; lack of response warrants therapy change 3, 4
• Consider culture if treatment fails: Rule out non-albicans species or resistant organisms 8, 6
• Evaluate for predisposing factors: Recent antibiotic use, immunodeficiency, or chronic conditions may require longer treatment or systemic therapy 1, 10